COMPANY
InfraScan, Inc.
Timeline
- Trial start —: SAFETY: Stabilization Points to Third Hospital Line Assessment oF the Impact of the usE of Infrascanner Model 2500 to Provide Decision Support for Diagnosis/Screening of Traumatic Brain InjurY in U source ↗
- Trial start Not phased (device or behavioral study): A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07014748 | SAFETY: Stabilization Points to Third Hospital Line Assessment oF the Impact of the usE of Infrascanner Model 2500 to Provide Decision Support for Diagnosis/Screening of Traumatic Brain InjurY in Ukraine | Not listed | Completed | Jan 17, 2025 | Mar 28, 2026 (actual) |
| NCT00576147 | A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection | Not phased (device or behavioral study) | Completed | 2006-07 | 2011-01 (actual) |
NIH awards 1
- NIH award 1R43HL084792-01A1 FY2007: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI BEN DOR, BARUCH; recipient as written: INFRASCAN, INC., PHILADELPHIA, PA. Portable Near Infrared Spectroscopy for gui source ↗
Connect
See your connections at InfraScan on LinkedIn (search by name, results not checked)